Bromide

Bromide

SCHEMBL286882

CCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.56
TRAP1 Q12931 2/20 0.46
CHRNA7 P36544 7/20 0.45
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
DNM1 Q05193 2/20 0.43
CSNK1E P49674 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2446607 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL678415 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL362235 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL1866839 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL7759526 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL635580 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL8775234 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL164301 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL2979400 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL1963378 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 367 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118209650-A Method for extracting and determining succinate dehydrogenase inhibitor based on magnetic eutectic solvent-liquid microextraction-high performance liquid chromatography 山西农业大学 2024-06-18 CN claimed
CN-118019801-A Fluoropolymer compositions and methods of making the same 阿科玛股份有限公司 2024-05-10 CN claimed
US-11428444-B2 Electrocaloric heat transfer system CARRIER CORPORATION (US) 2022-08-30 US claimed
EP-1973974-B1 A PROCESS FOR PREPARING 'ONIUM SALTS SUN CHEMICAL CORP (US) 2014-04-30 EP claimed
US-7863459-B2 Process for preparing onium salts SUN CHEMICAL CORPORATION (US) 2011-01-04 US claimed
US-20080287686-A1 Process for Preparing Onium Salts SUN CHEMICAL CORP (US) 2008-11-20 US claimed
EP-1973974-A2 A PROCESS FOR PREPARING 'ONIUM SALTS Sun Chemical Corporation (US) 2008-10-01 EP claimed
WO-2007075498-A2 A PROCESS FOR PREPARING 'ONIUM SALTS SUN CHEMICAL CORPORATION (US) 2007-07-05 WO claimed
EP-0877298-B1 Coated xerographic photographic paper XEROX CORP (US) 2001-08-29 EP claimed
US-5908723-A Recording sheets XEROX CORPORATION (US) 1999-06-01 US claimed
EP-0056679-B1 ETHANOL SYNTHESIS BY HOMOLOGATION OF METHANOL TEXACO DEVELOPMENT CORPORATION (US) 1985-04-17 EP claimed
US-4451679-A RUTHENIUM COMPOUNDS, PHOSPHONIUM OR QUATERNARY AMMONIUM COMPOUNDS TEXACO INC. (US) 1984-05-29 US claimed
US-4433176-A CONTAINING RUTHENIUM, COBALT AND RHODIUM COMPOUND AND ONIUM SALT TEXACO INC. (US) 1984-02-21 US claimed
US-4433178-A RUTHENIUM, COBALT CONTAINING COMPOUND, AND ONIUM SALT TEXACO, INC. (US) 1984-02-21 US claimed
US-4433177-A CONTAINING RUTHENIUM, COBALT COMPOUND, AN AMINE AND ONIUM SALT TEXACO INC. (US) 1984-02-21 US claimed
US-4414410-A COBALT, RUTHENIUM AND PHOSPHONIUM COMPOUNDS AS CATALYSTS TEXACO INC. (US) 1983-11-08 US claimed
US-4374285-A USING CARBON MONOXIDE AND HYDROGEN AND A CATALYST SYSTEM OF A RUTHENIUM COMPOUND, A QUATERNARY BASE AND A COBALT HALIDE TEXACO INC. (US) 1983-02-15 US claimed
US-4371724-A Ethanol synthesis by homologation of methanol TEXACO INC. (US) 1983-02-01 US claimed
EP-0056679-A1 Ethanol synthesis by homologation of methanol TEXACO DEVELOPMENT CORPORATION (US) 1982-07-28 EP claimed
US-4270015-A CATALYTIC ESTERIFICATION OF AN ACYCLIC ACID USING A COMPLEX OF A RUTHENIUM COMPOUND AND A CESIUM, QUATERNARY AMMONIUM, OR PHOSPHONIUM COMPOUND; PYROLYSIS TEXACO INC. (US) 1981-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287686-A1 Process for Preparing Onium Salts IK, NOTUM, NOS2 HIF1A 4488/4885TRAP1 4767/4885CHRNA7 255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.